Legal & General Group Plc Purchases New Position in Cabot Corporation $CBT

Legal & General Group Plc acquired a new position in shares of Cabot Corporation (NYSE:CBT) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 75,970 shares of the specialty chemicals company’s stock, valued at approximately $6,900,000. Legal & General Group Plc owned 0.15% of Cabot as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of Cabot in the 2nd quarter worth $633,302,000. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Cabot by 5.6% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock valued at $155,315,000 after acquiring an additional 124,613 shares in the last quarter. State Street Corp lifted its stake in Cabot by 1.0% in the fourth quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after acquiring an additional 20,021 shares during the period. Dimensional Fund Advisors LP lifted its stake in Cabot by 4.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock worth $131,253,000 after acquiring an additional 79,499 shares during the period. Finally, Bank of America Corp DE grew its holdings in Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after acquiring an additional 63,080 shares in the last quarter. 93.18% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Sean D. Keohane sold 134,895 shares of Cabot stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. This trade represents a 25.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last ninety days, insiders have sold 229,597 shares of company stock valued at $19,646,746. 3.08% of the stock is owned by company insiders.

Cabot Stock Up 2.8%

Shares of CBT stock opened at $82.90 on Thursday. The stock’s fifty day moving average price is $87.15 and its 200 day moving average price is $81.37. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $94.53. The company has a market cap of $4.28 billion, a price-to-earnings ratio of 23.35, a price-to-earnings-growth ratio of 10.59 and a beta of 0.83. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The firm’s revenue was up 6.4% compared to the same quarter last year. During the same period last year, the business posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, research analysts expect that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be given a $0.4725 dividend. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is presently 53.24%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CBT. JPMorgan Chase & Co. boosted their price target on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. UBS Group cut their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a report on Wednesday, August 5th. Truist Financial set a $100.00 price objective on shares of Cabot in a research note on Wednesday, August 5th. Mizuho upped their target price on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Two equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $89.00.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.